Setipiprant is a selective, orally available prostaglandin D2 receptor 2 (DP2) antagonist that has been investigated for the treatment of conditions such as asthma and male pattern hair loss. This category… Read more
Setipiprant is a selective, orally available prostaglandin D2 receptor 2 (DP2) antagonist that has been investigated for the treatment of conditions such as asthma and male pattern hair loss. This category provides access to high-quality Setipiprant reference standards alongside its associated impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these materials to perform accurate impurity profiling, facilitate method validation, and conduct rigorous quality control throughout the drug development lifecycle. By utilizing well-characterized standards, researchers can ensure the precision of analytical testing, enabling the identification and quantification of related substances and degradants. These materials are essential for maintaining strict compliance and regulatory standards when analyzing Setipiprant samples, supporting the development of consistent, high-purity pharmaceutical products.